Delivery Order SPE2DX22D0040-SPE2D826FA3KR
- Not listed
- This delivery order, valued at $145,629.91, was awarded on January 10, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., by the Defense Logistics Agency's Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed at the awardee's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of January...
- This delivery order, valued at approximately $34,900, was awarded on January 11, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply delivery to support federal healthcare needs. The award represents a non-competitive, firm fixed-price delivery order under the Defense Logistics Agency (DLA) Medical Supply Chain program, with performance based in Conshohocken, Pennsylvania, and a completion deadline of January 12, 2026....
- On January 6, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,276.00 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,584.40 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. The contract, designated as a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by January 13, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded and represents a routine...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,293.60 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., on January 6, 2026. This firm fixed-price, competitively awarded delivery order is scheduled for completion by January 7, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,295.84 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 8, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger indefinite delivery...
- On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,643.25 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, which has an ultimate completion date of January 9, 2026, was competitively awarded with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This delivery order, valued at $8,033.99, was awarded on January 12, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., by the Defense Logistics Agency Medical Supply Chain. The contract utilizes firm fixed-price pricing with no set-aside designation and is scheduled for ultimate completion on January 13, 2026. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and operates as a child entity under its...
- This delivery order, valued at $4,603.52, was awarded on January 12, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., with an ultimate completion date of January 13, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the Defense Logistics Agency's Medical Supply Chain. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerSourceBergen's corporate headquarters....
- This delivery order, valued at $1,441.95, was awarded on January 6, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. The award is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 6, 2026, and is performed at the vendor's location in Conshohocken, Pennsylvania. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for distributing medical...
- SPE2DX22D0040Indefinite Delivery Contract
- SPE2DX22D0040-SPE2D826FA3KRDelivery Order
This delivery order, valued at $37,954.48, was awarded on January 12, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply deliveries to support federal medical procurement needs. The contract is structured as a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The funding agency is the Defense Logistics Agency's Medical Supply Chain, a defense-focused organization responsible for supplying critical medical products to military and veteran healthcare systems. AmerSourceBergen Drug Corp's place of performance is based in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order operates under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The parent company, Cencora, Inc., also maintains a significant IDC with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, demonstrating the critical role both entities play in supporting military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.0k | 1/11/26 |